baber/WOPTO huggingface dataset:
Patent AU-607191-B2 (AU)
Title: Mono- and diepoxide derivatives of delta22-LL-F28249 compounds
Inventor: ASATO GORO
IPC: A01N43/90
Filed: 1988-03-04
Granted: 1991-02-28
Abstract: The present invention relates to novel derivatives of LL-F28249 compounds wherein the 23-hydroxyl group is eliminated to form a double bond at the C(22,23)-position ( DELTA <2><2>), and the double bond at the C(26,27)-position is epoxidized concomitant with or without epoxidation of the double bond at the C(14,15)-position. These LL-F28249 compounds (collectively) are isolates from the fermentation broth of Streptomyces cyaneogriseus subspecies noncyanogenus having deposit accession number NRRL 15773. The compounds of the present invention are derived by regioselective epoxidation of 5,23-O,O-bissilylated LL-F28249 compounds at low temperature, desilylation, re-silylation of the 5-hydroxyl group, thiocarbonylation of the 23-hydroxyl group, desilylation and thermalization. The novel compounds of the invention have anthelmintic, insecticidal, ectoparasiticidal, nematicidal and acaricidal activity. Compositions containing these described derivatives as active ingredients thereof are described herein.
Patent AU-668668-B2 (AU)
Title: Aldehyde resins with reduced and stabilized free-formaldehyde content
Inventor: ALBRECHT NORMAN G
IPC: C09J103/02
Filed: 1995-03-07
Granted: 1996-05-09
Abstract: A ketone/formaldehyde crosslinking additive having reduced and stabilized free-formaldehyde content and which are useful in starch based alkaline corrugating adhesive compositions are provided by a process wherein the ketone/aldehyde additives are treated with hydrogen peroxide and further with an urea compound.
Patent AU-780417-B2 (AU)
Title: Aplidine treatment of cancers
Inventor: FAIRCLOTH GLYNN THOMAS
IPC: A61P35/00
Filed: 2000-11-15
Granted: 2005-03-17
Abstract: Aplidine demonstrates considerable promise in phase (I) clinical trials for treatment of tumors, and various dosing regimes are given. Tumor reduction has been observed in several tumor types including renal carcinoma, colorectal cancer, lung carcinoid, medullary thyroid carcinomas and melanoma. It has also been found that aplidine has a role in inhibiting angiogenesis, complementing the anti-tumor activity.
Patent AU-740143-B2 (AU)
Title: Process to manange data in a chip card
Inventor: LISIMAQUE GILLES
IPC: G07F7/08
Filed: 1998-11-24
Granted: 2001-11-01
Abstract: The invention concerns a method for duplicating data contained a smart card (9) memory in the memory of another smart card (2), which consists in producing for said other card another management code (22), another secret code. Said other management code is produced on the basis of identification data particular to the first card (12) and also particular to the second card (23). For the system to operate, identification data (12) concerning the first card are also recorded in the second card.
Patent AU-781112-B2 (AU)
Title: Films with improved blocking resistance and surface properties
Inventor: MIGLIORINI ROBERT
IPC: C08J7/00
Filed: 2000-11-01
Granted: 2005-05-05
Abstract: The invention discloses methods of improving blocking resistant properties and reducing the coefficient of friction of a multilayer film comprising providing at least one layer of an ethylene-propylene impact copolymer having from about 3% to about 30% by weight ethylene, wherein said copolymer has no more than two peaks in the melting curve within the range from about 110° C. to about 165° C., and wherein said layer is non-heat sealable, to a multilayer film having a core layer comprising polypropylene, high density polyethylene (HDPE) or linear low density polyethylene (LLDPE), whereby anti-blocking and coefficient of friction characteristics of said film is improved without necessity of adding an antiblock or slip agent.
Patent AU-617323-B2 (AU)
Title: Mutant t-pa with kringle replacement
Inventor: MULVIHILL EILEEN R
IPC: C12P21/02
Filed: 1988-06-06
Granted: 1991-11-28
Abstract: Tissue plasminogen activator analogs exhibiting greater specificity for fibrin than native t-PA are disclosed. The analogs include the K1 domain of native t-PA replaced with another kringle domain mediating the binding of the analog to fibrin. The kringle contains six cysteine residues. The t-PA analogs may further include a variety of substitutions and modifications. Pharmaceutical compositions containing one or more of the t-PA analogs along with a physiologically acceptable carrier or diluent are also disclosed.
Patent AU-690667-B2 (AU)
Title: Enhanced virus-mediated DNA transfer
Inventor: WILLIAMS DAVID A
IPC: A61K47/48
Filed: 1995-03-27
Granted: 1998-04-30
Abstract: A method to increase the efficiency of transduction of hematopoietic and other cells by retroviruses includes infecting the cells in the presence of fibronectin or fibronectin fragments. As can be seen in the figure the fibronectin and fibronectin fragments significantly enhance retroviral-mediated gene transfer into the cells, particularly hematopoietic cells including committed progenitors and primitive hematopoietic stem cells. The invention also provides improved methods for somatic gene therapy capitalizing on enhanced gene transfer, hematopoietic cellular populations, and novel constructs for enhancing retroviral-mediated DNA transfer into cells and their use.
Patent AU-730537-B2 (AU)
Title: Methods and compositions for transforming dendritic cells and activating T cells
Inventor: HWU PATRICK
IPC: A61K39/00
Filed: 1997-02-07
Granted: 2001-03-08
Abstract: Recombinant dendritic cells are made by transforming a stem cell and differentiating the stem cell into a dendritic cell. The resulting dendritic cell is an antigen presenting cell which activates T cells against MHC class I-antigen targets. Kits, assays and therapeutics are based upon the activation of T cells by the recombinant dendritic cell. Cancer, viral infections and parasitic infections are all ameliorated by the recombinant dendritic cells, or corresponding activated T cells. Therapeutic compositions and pharmaceutical compositions are provided.
Patent AU-604978-B2 (AU)
Title: Thickeners for physically drying paints and coating materials and preparation of the thickeners
Inventor: KRAUSE HANS-JOACHIM
IPC: C09D7/00
Filed: 1988-09-30
Granted: 1991-01-03
Abstract: The thickening agent (thickener) for physically drying paints and coatings which contain binders which are soluble in white spirit is a copolymer which forms a gel in white spirit and contains (a) from 7 to 15% by weight of acrylates and/or methacrylates of monoalkanols having 8 carbon atoms,  (b) from 0.05 to 0.2% by weight of a crosslinking agent,  (c) from 25 to 35% by weight of styrene and (d) from 49.8 to 67.95% by weight of at least one acrylate and/or methacrylate of monoalkanols having 4 carbon atoms, in copolymerised form, with the proviso that the total of the % by weight for (a) to (d) is always 100. The thickener is prepared by emulsion polymerisation of the parent monomers in the presence of alkylsulphonates as emulsifier.
Patent AU-594894-B2 (AU)
Title: Process and device for treating a photographic recording material
Inventor: GANZKE JURGEN
IPC: G03F7/30
Filed: 1988-10-07
Granted: 1990-03-15
Abstract: Process and device for treating photosensitive recording material comprising a carrier layer and at least one photosensitive recording layer having a hardened image, e.g., halftone images, whereby undesirable streaks are eliminated particularly in halftone areas, the recording material while being transported flat is successively treated with washing agent in at least two separated wash sections by jets shaped and arranged so that each surface unit area of the recording layer is sequentially struck by at least two wash spray cones which do not contact each other prior to impacting the recording layer. The amount of washing agent impacting a unit area of the surface of the recording material per unit time and its impact velocity are selected so that only image free areas of the recording layer are removed. Halftone copies reproduction printing forms, etc., are produced.
Patent AU-619217-B2 (AU)
Title: Iodine mirobicide composition
Inventor: MURAKAMI YUJI
IPC: A01N25/02
Filed: 1988-11-02
Granted: 1992-01-23
Abstract: A substantially non-aqueous iodine microbicide composition comprising (a) a povidone-iodinein in an amount of from 0.0005% to 1.0% by weight based on the total amount of the compsition, and (b) a solvent comprising a lower alcohol having from 1 to 3 carbon atoms or a mixture of a lower alcohol having from 1 to 3 carbon atoms and a non-hydrated polyhydric alcohol, and an aerosol-type iodine microbicide composition containing the iodine microbicide composition.
Patent AU-757506-B2 (AU)
Title: Game system
Inventor: KUSUDA KAZUHIRO
IPC: G07F17/32
Filed: 2000-03-31
Granted: 2003-02-20
Abstract: A game system which is capable of ensuring continuity of a game is provided. A game system for paying for recreation value according to progress of a game, has a magnetic information reading device for reading information in an attachable/detachable recording medium, an SRAM for storing state and history of a suspended game corresponding to each of the recording media, and a medal management device for paying for recreation value according to progress of the game. Specifying information for specifying each of the recording media is recorded in each of the recording media, the state and history of the game are stored in the SRAM corresponding to the specifying information, and the rest of the game is continuously progressed by using the state and history of the game which were stored in the RAM corresponding to the specifying information read by the magnetic information reading device. <IMAGE>   <IMAGE>
Patent AU-770036-B2 (AU)
Title: Removal/purification of serum albumins
Inventor: REGBERG TOR
IPC: C07K14/765
Filed: 1999-12-20
Granted: 2004-02-12
Abstract: A method for selectively enriching/removing a serum albumin from a mixture of other compounds by contacting said mixture with M-B-X where M is matrix, B the spacer and X the affinity ligand, with the provision that M may contain further groups X linked via a spacer. The characterizing feature is that the ligand X has been selected among serum albumin-binding structures complying with the formula (I) in which the free valence binds to the spacer B; R1-10 are selected from hydrogen, electron-withdrawing groups, such as halogens and lower alkyl groups (C1-10) that possibly are substituted with electron withdrawing groups, such as halogens; Z and Y are selected among oxygen, sulphur or nitrogen, with the provision that the nitrogen may carry a positive charge. A method for screening for ligands structures that, when attached to an affinity matrix, selectively bind serum albumin. The method has the characterizing feature that water-soluble compounds that exhibit a benzene ring fused to a 5-membered heterocycle containing two or three heteroatoms, preferably two, selected from nitrogen, oxygen and sulphur after having been attached to a matrix, preferably in the 2-position, are screened for selective binding to albumin.
Patent AU-716400-B2 (AU)
Title: Device and method for treating ophthalmic diseases
Inventor: SPEAR PETER D
IPC: A61K9/52
Filed: 1997-03-24
Granted: 2000-02-24
Abstract: A method and device for delivering a biologically active molecule to the eye, either intraocularly or periocularly, and method and device for treating ophthalmic disorders in a patient suffering therefrom. <IMAGE> <IMAGE>
Patent AU-779128-B2 (AU)
Title: Method of treating restenosis by antisense targeting of c-myc
Inventor: IVERSEN PATRICK L
IPC: C12Q1/6883
Filed: 2000-01-29
Granted: 2005-01-06
Abstract: The present invention provides a method for targeting a particular mRNA sequence in vivo by oral administration of a morpholino antisense compound having uncharged phosphorus-containing backbone linkages. Also disclosed is a non-invasive method of detecting and quantitating the in vivo presence of RNA containing one or more selected target sequences. The method includes administering to a subject a nuclease-resistant antisense oligomer which hybridizes by Watson-Crick base pairing to a region of the target RNA with a Tm substantially greater than 37° C. The oligomer is able to complex intracellularly with target RNA, and is released from intracellular sites as a nuclease-resistant heteroduplex, which can then be measured in a body fluid sample, e.g., urine.
Patent AU-652292-B2 (AU)
Title: Data flow control
Inventor: KULLANDER JAN
IPC: H04L47/30
Filed: 1992-09-21
Granted: 1994-08-18
Abstract: The invention relates to a method for monitoring and controlling the data flow in a packet data net or a datagram net comprising lines and nodes, the lines via nodes connecting by the network comprised terminals between which traffic takes place in the form of data packets or datagram. Every line and every node comprises a process preceded by a certain queue of data packets/datagram. Data packets are sent in to the net from the terminal for with a given frequency during a given time interval. If during this interval no throttling order is received from the following process, the frequency is increased by a given factor. This occurs successively until a given maximum frequency is reached. If on the other hand a throttling order is received during the interval, the frequency is instead reduced by a given factor which also occurs successively until no throttling order is received during an interval. <IMAGE>
Patent AU-672370-B2 (AU)
Title: New derivatives of fluoro-quinoline carboxylic-3 acid and preparation thereof
Inventor: DAUBIE CHRISTOPHE
IPC: A61K31/445
Filed: 1992-10-08
Granted: 1996-10-03
Abstract: New fluoro-3-quinolinecarboxylic acid derivatives of general formula (I), in which R is a hydrogen atom or an alkyl radical and Hal is a halogen atom, and its salts where such exist, their preparation and their use as synthetic intermediates. <IMAGE>
Patent AU-668917-B2 (AU)
Title: Veterinary drug residue surveillance in fresh meat
Inventor: O'CONNOR MICHAEL
IPC: G01N33/94
Filed: 1993-03-01
Granted: 1996-05-23
Abstract: PCT No. PCT/IE93/00007 Sec. 371 Date Sep. 1, 1994 Sec. 102(e) Date Sep. 1, 1994 PCT Filed Mar. 1, 1993 PCT Pub. No. WO93/18408 PCT Pub. Date Sep. 16, 1993A method for the rapid detection of drug residues in livestock to allow quality certification, involves: taking a bile sample from livestock; cleaning the bile sample by passing the sample under vacuum through a porous silica immunoaffinity column having an immobilized antibody capable of binding the drug to be detected, washing the column free of impurities, and eluting any drug being bound to the column with a suitable solvent; and reacting the cleaned bile sample in a competitive immunometric assay utilizing a labelled antibody.
Patent AU-717706-B2 (AU)
Title: A seating unit
Inventor: DRYBURGH IAN
IPC: B60N2/90
Filed: 1999-06-18
Granted: 2000-03-30
Abstract: A seating unit (1) comprises a fixed housing (10) containing a primary seat with a reclinable back arranged to recline in such a manner that it remains within the housing. The seating unit is suitable for a aircraft cabin and may further comprise a leg-rest arranged to cooperate with the seating portion to form part of a substantially flat surface when the back is reclined in a substantially horizontal position. The seating unit may further comprise a secondary seat (3) positioned to face the primary seat, the secondary seat having a seating portion positioned to cooperate with the leg-rest of the primary seat to form a portion of the substantially flat surface when the back of the primary seat is reclined in the substantially horizontal position. Privacy between seats and use of available space within an aircraft cabin may be optimised by arranging at least some of the seats in an echelon. <IMAGE>
Patent AU-713729-B2 (AU)
Title: Electronically controlled wastegate valve
Inventor: ZURLO JAMES R
IPC: F02D41/00
Filed: 1997-09-01
Granted: 1999-12-09
Abstract: An electronically controlled wastegate valve is adjusted so that the pressure drop across a throttle in the engine approaches an adaptively generated, desired throttle pressure reserve value. The desired throttle pressure reserve value is based at least in part on a history of the engine load. In the preferred embodiment, the engine speed is used as a surrogate for engine load to determine the desired throttle pressure reserve value. The desired throttle pressure reserve value is preferably pushed downward over time by use of a constant negative gain term in the electronic controller. In this manner, the wastegate control provides sufficient throttle pressure reserve for satisfactory load acceptance when engine load is fluctuating, yet minimizes throttle pressure reserve to improve engine fuel consumption when the engine load is relatively steady. <IMAGE>
Patent AU-574770-B2 (AU)
Title: Electro winning copper
Inventor: SUAREZ-INFANZON LUIS ALONSO
IPC: C25C1/12
Filed: 1985-03-29
Granted: 1988-07-14
Abstract: The invention relates to a new procedure for electro-winning copper out from copper chloride aqueous solution electrolysis, wherein the use of an electrolysts cell is provided for, where the anodic and cathodic compartments, and the corresponding electrolytes, are separated by a cation permoselective membrane, and the liquid currents feeding both electrolytes (29, 31) have different composition, being the catholyte (29) a solution of copper and sodium chlorides as well as hydrochloric acid, and the anolyte (31) an alkaline chloride solution, preferably a sodium chloride one.
Patent AU-627489-B2 (AU)
Title: The use of transglutaminases as immunosuppressants
Inventor: STIEF THOMAS
IPC: A61K38/43
Filed: 1989-08-30
Granted: 1992-08-27
Abstract: It is described how transglutaminases can be used in a process for preparing an immunosuppressive agent. Also described is a medicament containing a transglutaminase and a plasminogen activator inhibitor.
Patent AU-626925-B2 (AU)
Title: Method for sending a plurality of data channels over a single communications line
Inventor: BURTON RICHARD J
IPC: H04L69/14
Filed: 1989-10-17
Granted: 1992-08-13
Abstract: A method for communicating with a plurality of hosts connected to an X.25 network and for selectably using a character as a control character or a data character. Each character received from the X.25 network is inspected to determine if it is one of a set of reserved characters. If so, the character is encoded before being sent to its final destination. Data intended for the X.25 network is inspected for the presence of a predetermined control character. If the control character is present, the next character is inspected to determine whether it is a command character or an encoded data character. If this next character is an encoded data character, it is decoded and provided to the X.25 network. If this next character is a command character, then the command is executed. The method allows the use of any character as either a command character or data character. Data transfer between the DTE and DCE is assigned a PAD and a virtual channel number which corresponds to a particular host on the X.25 network. The channel number may, but need not, be the same as the X.25 device address for that host. The method therefore allows the DTE and DCE to simultaneously communicate with a plurality of X.25 hosts over a single telephone line or physical transmission link.
Patent AU-712097-B2 (AU)
Title: Transferring accumulated data from vehicles
Inventor: HARRISON CHRISTOPHER GERARD
IPC: G08G1/127
Filed: 1997-09-16
Granted: 1999-10-28
Abstract: A data monitoring apparatus uses a GPS receiver, micro controller, a plurality of sensors and actuators, a memory, a radio transmitter and a data communication antennae. The apparatus accumulates real-time data concerning position and time and other operational parameters of a geographically mobile object for example a vehicle for transmission to a monitoring station. Transmission channel utility may be improved through transmission of accumulated historical data to a separate monitoring station.
Patent AU-778317-B2 (AU)
Title: Device and method for coating workpieces
Inventor: DOLKER GERHARD
IPC: B27M3/18
Filed: 2001-05-11
Granted: 2004-11-25
Abstract: The device has a support system with a base plate having a number of lifting pins arranged in a grid. The height of the lifting pins can be adjusted between rest and coating positions with respect to the base plate. The lifting pins are adjusted using pneumatic actuators (12) and are secured at the desired height by mechanical locking strips (13) that engage the lifting pins. An Independent claim is included for a method for using the device.
Patent AU-572682-B2 (AU)
Title: Pyroglutamic acid esters, their synthesis and use in topical products
Inventor: BLACK JOHN GORDON
IPC: C07D207/28
Filed: 1985-08-16
Granted: 1988-05-12
Abstract: Esters of pyroglutamic acid having the structure:   <IMAGE> (1) where R' and R'' are the same or different and are each represented by H or the grouping CH3[(CH2)w(CHCH3)x(CHOH)y(CH=CH)z]- where n is an integer of from 1 to 3 w is zero, or an integer of from 1 to 21 x is zero, or an integer of from 1 to 4 y is zero, or an integer of from 1 to 2 z is zero, or an integer of from 1 to 4 provided that the total number of carbon atoms in each of said grouping will not exceed 22; and provided also that when the subgrouping (CH=CH) is present, then the total number of carbon atoms in said grouping will be from 16 to 22. Synthesis, and uses of the said esters in topical compositions are also provided.
Patent AU-677223-B2 (AU)
Title: Method and kits for detection of bacteria
Inventor: SANDERS MICHAEL FREDERICK
IPC: C12Q1/689
Filed: 1993-09-22
Granted: 1997-04-17
Abstract: A method for detection, identification and/or quantification of target organisms of specific bacterial genus, species or serotype, based upon the occurrence of release of cell contents, particularly nucleotides e.g. ATP, on lysis of bacterial cell walls on incubation with bacteriophages (phages) specific for them. When new phage particles are released at the end of the phage replication cycle nucleotide levels are measured and compared with controls. The method provides for the detection of specific bacteria in which insertion of the lux gene into the phage genome is not required yet it is faster and more sensitive than known non-modified phage utilising techniques. The method is only limited by the availability of phage types suitable for selective attack of the target bacteria to be detected and can detect a single Salmonella in a sample of milk in under 12 hours.
Patent AU-583059-B2 (AU)
Title: Fluid pack with handle
Inventor: PUPP HERWIG
IPC: B65D5/46
Filed: 1985-10-08
Granted: 1989-04-20
Abstract: A pack for containing materials which are capable of flow includes a tube formed by a longitudinal sealing seam, along with a bottom and a cover closing the tube ends. The cover is formed from thermoplastic material without a carrier material, is injected on the tube, and has a pouring spout. The tube comprises cardboard which is coated with thermoplastic material on one side. The bottom is quadrangular, formed from the folded-over tube of the pack of a fold-type closure. The cover and the cross-section of the pack, at least in the region of the cover, are round. To improve such a pack with a handle so that the final consumer enjoys improved handleability and transportability, the invention provides that a portion of the tube wall, which adjoins the periphery of the cover, is folded onto itself, forming a handle, and is joined to provide a double-wall surface portion in which a gripping opening is provided. The cover is extended over the upper edge of the double-wall surface portion with the gripping opening to provide a stiffening web.